Volume-2 Issue-4

  • Version
  • Download 34
  • File Size 4.00 KB
  • Create Date April 16, 2018
  • Download

Download Abstract Book

S. No

Volume-2 Issue-4, April 2018, ISSN: 2394-367X (Online)
Published By: Blue Eyes Intelligence Engineering & Sciences Publication Pvt. Ltd.

Page No.



Divya Sanganabhatla, R. Shyam Sunder, Harshit Malpani

Paper Title:

Introduction To Solid Lipid Nano Particles- An Overview

Abstract: Solid lipid nanoparticles are of major importance to the developing field of nano technology with applications in drug delivery, research and clinical medicine and other sciences. SLN dispersions have been proposed as a new type of colloidal drug carrier system suitable for intravenous administration. Solid lipid nanoparticles are submicron colloidal carriers composed of a single lipid core matrix that is solid at body temperature, and is coated with a surfactant acting as stabilizer. The conventional approaches such as use of permeation enhancers, surface modification, prodrug synthesis, complex formation and colloidal lipid carrier based strategies have been developed for the delivery of drugs to intestinal lymphatics. Aspects of solid lipid nanoparticles route of administration and their bio distribution are also incorporated. If appropriately investigated, solid lipid nanoparticles may open new vistas in therapy of complex diseases. It also discusses the potential of SLNs in brain targeting

Keywords: Nano Particles, Solid Lipid Nanoparticles (SLNs), TEM, PCS, Bio Distribution.


  1. Liversidge GG and Cundy KC: Particle size reduction for improvement of oral bioavailability of hydrophobic drugs. Absolute oral bioavailability of nanocrystallined danazol in beagle dogs. Int J Pharm 1995; 125:91-97.
  2. Olbrich C, Gebner A, Kayser O, Muller RH. Lipid–drug conjugate (LDC) nanoparticles as novel carrier system for the hydrophilic antitrypanosomal drug diminazenediaceturate. J Drug Target. 2002;10:387–96.
  3. Wolfgang Mehnert, Karsten Mader,; Solid lipid nanoparticles: Production,characterization and applications;Advanced Drug Delivery Reviews 47, (2001),165– 196
  4. Mullen zur A. Feste Lipid-Nanopartikel mit prolongierter Wirkstoffliberation: Herstellung, Langzeitstabilitat, Charakterisierung, Freisetzungsverhalten und mechanismen. Ph.D. Thesis, Free University of Berlin. 1996
  5. Eldem T, Speiser P, Hincal A. Optimization of spray-dried and congealed lipid microparticles and characterization of their surface morphology by scanning electron microscopy. Pharm Res 1991;8:47-54.
  6. Speiser P. Lipidnanopellets als Tragersystem fur Arzneimittel zur peroralem Anwendung. European Patent No. EP 0167825; 1990.
  7. Sjostrom B, Bergenstahl B. Preparation of submicron drug particles in lecithin-stabilized o/w emulsions. I. Model studies of the precipitation of cholesteryl acetate. Int J Pharm 1992;88:53-.62.
  8. Siekmann B, Westesen K. Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions. Eur J Pharm Biopharm 1996;43:104-9.
  9. Freitas C, Mullera RH. Spray-drying of Solid lipid nanoparticles (SLN TM). Eur J Pharm Biopharm 1998;46:145-51.
  10. Killeen M.J. Spray drying and spray congealing of pharmaceuticals. In Encyclopedia of Pharmaceutical Technology. Edited by Swarbrick J. Boylan JC 2000